Inhibiting Cholesterol-associated Protein Reduces High-risk Blockages In Arteries, University of Pennsylvania School of Medicine Study
ScienceDaily (Sep. 28, 2008) — Using the drug darapladib, researchers at the University of Pennsylvania School of Medicine and colleagues have inhibited a cholesterol-and immune system-associated protein, thereby reducing the development of heart-disease plaques that may cause death, heart attacks, and strokes in a pig model of atherosclerosis and diabetes.